Naoki Hirayama is an Investment Manager at Remiges Ventures, seconded from Taiho Pharmaceutical since February 2026. He has over 20 years of clinical development experience in oncology trials.
At firms with a similar stage, sector and check size.
One email when Naoki's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckNaoki Hirayama is an Investment Manager at Remiges Ventures, seconded from Taiho Pharmaceutical since February 2026. He has over 20 years of clinical development experience in oncology trials.
Remiges Ventures has not reported a check size. It invests at seed.
A warm intro from a founder Remiges Ventures backed works best.
clinical research associate, team leader, product chair at Taiho Pharmaceutical Co., Ltd..
Last updated 2026-10-15. Is this you? Ask for a correction.